vs

Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and Solana Co (HSDT). Click either name above to swap in a different company.

CRYO CELL INTERNATIONAL INC is the larger business by last-quarter revenue ($7.8M vs $5.2M, roughly 1.5× Solana Co). Solana Co runs the higher net margin — 6227.1% vs -48.7%, a 6275.7% gap on every dollar of revenue. On growth, Solana Co posted the faster year-over-year revenue change (2725.9% vs -2.3%). Over the past eight quarters, Solana Co's revenue compounded faster (522.3% CAGR vs -0.1%).

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

Solana is a Mexican cottage manufacturer of sports, racing, and kids' automobiles based in Mexico City. The family run company has operated since 1936, with a total production of fewer than fifty cars; the majority of them one-offs. The family is heavily involved in motor sports; the most prominent member was Moisés Solana, who raced family-built cars and later in Formula One.

CCEL vs HSDT — Head-to-Head

Bigger by revenue
CCEL
CCEL
1.5× larger
CCEL
$7.8M
$5.2M
HSDT
Growing faster (revenue YoY)
HSDT
HSDT
+2728.2% gap
HSDT
2725.9%
-2.3%
CCEL
Higher net margin
HSDT
HSDT
6275.7% more per $
HSDT
6227.1%
-48.7%
CCEL
Faster 2-yr revenue CAGR
HSDT
HSDT
Annualised
HSDT
522.3%
-0.1%
CCEL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCEL
CCEL
HSDT
HSDT
Revenue
$7.8M
$5.2M
Net Profit
$-3.8M
$325.6M
Gross Margin
77.9%
96.6%
Operating Margin
-50.6%
-3845.8%
Net Margin
-48.7%
6227.1%
Revenue YoY
-2.3%
2725.9%
Net Profit YoY
-105.1%
8388.0%
EPS (diluted)
$-0.46
$111.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCEL
CCEL
HSDT
HSDT
Q4 25
$7.8M
$5.2M
Q3 25
$7.8M
$697.0K
Q2 25
$7.9M
$43.0K
Q1 25
$8.0M
$49.0K
Q4 24
$8.0M
$185.0K
Q3 24
$8.1M
$51.0K
Q2 24
$8.0M
$182.0K
Q1 24
$7.9M
$135.0K
Net Profit
CCEL
CCEL
HSDT
HSDT
Q4 25
$-3.8M
$325.6M
Q3 25
$749.4K
$-352.8M
Q2 25
$355.8K
$-9.8M
Q1 25
$282.9K
$-3.8M
Q4 24
$-1.9M
Q3 24
$1.1M
$-3.7M
Q2 24
$655.8K
$-1.6M
Q1 24
$556.2K
$-2.5M
Gross Margin
CCEL
CCEL
HSDT
HSDT
Q4 25
77.9%
96.6%
Q3 25
77.0%
85.2%
Q2 25
76.6%
Q1 25
75.1%
Q4 24
78.4%
16.8%
Q3 24
73.6%
Q2 24
74.8%
35.2%
Q1 24
73.7%
8.9%
Operating Margin
CCEL
CCEL
HSDT
HSDT
Q4 25
-50.6%
-3845.8%
Q3 25
24.3%
-5086.1%
Q2 25
18.8%
-7725.6%
Q1 25
13.3%
-8185.7%
Q4 24
-1.5%
Q3 24
17.2%
-7980.4%
Q2 24
17.3%
-1796.7%
Q1 24
10.5%
-2530.4%
Net Margin
CCEL
CCEL
HSDT
HSDT
Q4 25
-48.7%
6227.1%
Q3 25
9.6%
-50612.3%
Q2 25
4.5%
-22867.4%
Q1 25
3.5%
-7832.7%
Q4 24
-23.2%
Q3 24
13.0%
-7227.5%
Q2 24
8.2%
-885.7%
Q1 24
7.1%
-1863.7%
EPS (diluted)
CCEL
CCEL
HSDT
HSDT
Q4 25
$-0.46
$111.28
Q3 25
$0.09
$-32.89
Q2 25
$0.04
$-79.73
Q1 25
$0.03
$-0.51
Q4 24
$-0.23
Q3 24
$0.13
$-744.35
Q2 24
$0.08
$-485.30
Q1 24
$0.07
$-3.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCEL
CCEL
HSDT
HSDT
Cash + ST InvestmentsLiquidity on hand
$3.3M
$7.3M
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$-18.6M
$300.9M
Total Assets
$61.7M
$303.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCEL
CCEL
HSDT
HSDT
Q4 25
$3.3M
$7.3M
Q3 25
$3.2M
$124.1M
Q2 25
$4.4M
$6.1M
Q1 25
$3.5M
$1.1M
Q4 24
$3.5M
$1.1M
Q3 24
$2.1M
$3.5M
Q2 24
$1.5M
$6.4M
Q1 24
$979.6K
$3.6M
Total Debt
CCEL
CCEL
HSDT
HSDT
Q4 25
$8.4M
Q3 25
$8.4M
Q2 25
$8.4M
Q1 25
$8.5M
Q4 24
$8.5M
Q3 24
$8.5M
Q2 24
$8.5M
Q1 24
$8.6M
Stockholders' Equity
CCEL
CCEL
HSDT
HSDT
Q4 25
$-18.6M
$300.9M
Q3 25
$-14.8M
$-152.4M
Q2 25
$-15.6M
$6.0M
Q1 25
$-14.7M
$1.3M
Q4 24
$-13.2M
$1.1M
Q3 24
$-9.6M
$3.8M
Q2 24
$-10.7M
$6.3M
Q1 24
$-10.3M
$2.0M
Total Assets
CCEL
CCEL
HSDT
HSDT
Q4 25
$61.7M
$303.9M
Q3 25
$63.2M
$475.9M
Q2 25
$64.4M
$7.9M
Q1 25
$64.4M
$3.5M
Q4 24
$64.7M
$3.5M
Q3 24
$62.9M
$5.6M
Q2 24
$62.6M
$8.8M
Q1 24
$61.7M
$5.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCEL
CCEL
HSDT
HSDT
Operating Cash FlowLast quarter
$1.3M
$-16.5M
Free Cash FlowOCF − Capex
$1.2M
FCF MarginFCF / Revenue
15.5%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
-0.05×
TTM Free Cash FlowTrailing 4 quarters
$5.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCEL
CCEL
HSDT
HSDT
Q4 25
$1.3M
$-16.5M
Q3 25
$2.5M
$-4.0M
Q2 25
$707.0K
$-2.8M
Q1 25
$954.1K
$-3.5M
Q4 24
$2.2M
$-11.0M
Q3 24
$2.4M
$-2.8M
Q2 24
$1.8M
$-2.9M
Q1 24
$-356.9K
$-3.0M
Free Cash Flow
CCEL
CCEL
HSDT
HSDT
Q4 25
$1.2M
Q3 25
$2.5M
Q2 25
$644.6K
Q1 25
$892.0K
Q4 24
$2.1M
$-11.0M
Q3 24
$2.3M
Q2 24
$21.5K
Q1 24
$-814.6K
$-3.0M
FCF Margin
CCEL
CCEL
HSDT
HSDT
Q4 25
15.5%
Q3 25
31.9%
Q2 25
8.1%
Q1 25
11.2%
Q4 24
26.8%
-5970.8%
Q3 24
27.9%
Q2 24
0.3%
Q1 24
-10.4%
-2226.7%
Capex Intensity
CCEL
CCEL
HSDT
HSDT
Q4 25
0.9%
Q3 25
0.5%
Q2 25
0.8%
Q1 25
0.8%
Q4 24
0.1%
2.7%
Q3 24
2.3%
0.0%
Q2 24
21.8%
0.0%
Q1 24
5.8%
3.7%
Cash Conversion
CCEL
CCEL
HSDT
HSDT
Q4 25
-0.05×
Q3 25
3.38×
Q2 25
1.99×
Q1 25
3.37×
Q4 24
Q3 24
2.32×
Q2 24
2.70×
Q1 24
-0.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons